Brain Mitochondrial Dysfunction and Complex I Syndrome in Parkinson ́s Disease

  • B. L
  • J. M
  • Navarro A
  • et al.
N/ACitations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

1.1 Clinical characteristics of Parkinson’s disease Parkinson’s disease (PD) is an old-age neurodegenerative disease with a small but significant genetic risk. The prevalence of PD is of 0.3% in the whole population, affecting more than 1% of the humans over 60 years of age (de Lau & Breteler, 2006). Parkinson s disease is characterized by the progressive loss of dopamine due to degeneration of dopaminergic neurons in the substancia nigra, striatum body and brain cortex. In addition, αsynuclein-positive Lewy bodies in brainstem and neocortex are consistently found at autopsy (Forno, 1996; Jellinger & Mizuno, 2003). Therefore, in patients with PD, movements, sleep, autonomic functions and cognition become progressively impaired. Complex factors contribute to the appearance of PD but with a constant mitochondrial involvement and a decreased capacity to produce energy (ATP) in the affected brain areas (Shapira, 1998; Shapira, 2008). Mitochondrial dysfunction in the human frontal cortex is to be considered a factor contributing to impaired cognition in PD.

Cite

CITATION STYLE

APA

B., L., J., M., Navarro, A., & Boveris, A. (2011). Brain Mitochondrial Dysfunction and Complex I Syndrome in Parkinson ́s Disease. In Etiology and Pathophysiology of Parkinson’s Disease. InTech. https://doi.org/10.5772/34847

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free